Juan-Manuel Sancho

34PUBLICATIONS
132CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesAllergyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 06, 2026
Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO Trial.

|Jun 26, 2026
Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. Cancers 2026, 18, 395.

|Feb 13, 2026
Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2025.

Francisco-Javier Peñalver, Laura Magnano, Sara Alonso-Álvarez

|Jan 07, 2026
Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma.

Gloria Iacoboni, Emil Ramsø Kyvsgaard, Víctor Navarro Garcés

|Oct 01, 2025
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy.

Anna Torrent, Mireia Morgades, Gloria Iacoboni

|May 01, 2025
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.

Michael Wang, David Salek, David Belada

Pageof 6

Frequent Collaborators

6 joint publications

Armando López-Guillermo

4 joint publications

Raúl Córdoba

4 joint publications

Santiago Mercadal

4 joint publications

Mariana Beatriz Bastos Oreiro